Literature DB >> 19576745

Nontuberculous mycobacteria isolated during the treatment of pulmonary tuberculosis.

Hee-Jung Jun1, Kyeongman Jeon, Sang-Won Um, O Jung Kwon, Nam Yong Lee, Won-Jung Koh.   

Abstract

BACKGROUND: The significance of nontuberculous mycobacteria (NTM) isolated from a patient during therapy for pulmonary tuberculosis (TB) is uncertain. We investigated the frequency and clinical significance of NTM isolated from patients receiving anti-TB treatment.
METHODS: We conducted a retrospective cohort study of all patients with culture-confirmed pulmonary TB, and identified patients with respiratory cultures positive for NTM during therapy for pulmonary TB.
RESULTS: From January 2003 to December 2005, 958 patients were diagnosed with culture-confirmed pulmonary TB. NTM were isolated from 113 specimens in 68 (7.1%) patients during anti-TB treatment. The most frequently isolated NTM species were Mycobacterium abscessus (n=35, 31%), Mycobacterium fortuitum (n=17, 15%), Mycobacterium avium complex (n=9, 8%), and Mycobacterium gordonae (n=9, 8%). Forty-eight (71%) patients had only one positive culture, while 20 (29%) had two or more positive cultures for NTM. Only two (3%) patients who had two or more positive culture after anti-TB treatment showed the same NTM species, which were M. abscessus.
CONCLUSION: The isolation of NTM in patients with pulmonary TB is not uncommon during anti-TB treatment. However, this is likely the result of colonization, a transient infection, or specimen contamination. The co-existence of pulmonary TB and NTM lung disease may be rare but should be considered in patients with relatively virulent NTM species such as M. abscessus.

Entities:  

Mesh:

Year:  2009        PMID: 19576745     DOI: 10.1016/j.rmed.2009.05.025

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  11 in total

1.  Species Typing of Nontuberculous Mycobacteria by Use of Deoxyribozyme Sensors.

Authors:  Hillary N Wood; Ashelyn E Sidders; Lauren E Brumsey; Evgeny S Morozkin; Yulia V Gerasimova; Kyle H Rohde
Journal:  Clin Chem       Date:  2018-12-06       Impact factor: 8.327

2.  The significance of Mycobacterium abscessus subspecies abscessus isolation during Mycobacterium avium complex lung disease therapy.

Authors:  David E Griffith; Julie V Philley; Barbara A Brown-Elliott; Jeana L Benwill; Sara Shepherd; Deanna York; Richard J Wallace
Journal:  Chest       Date:  2015-05       Impact factor: 9.410

3.  Evaluation of two line probe assays for rapid detection of Mycobacterium tuberculosis, tuberculosis (TB) drug resistance, and non-TB Mycobacteria in HIV-infected individuals with suspected TB.

Authors:  Anne F Luetkemeyer; Michelle A Kendall; Xingye Wu; Maria Cristina Lourenço; Ute Jentsch; Susan Swindells; Sarojini S Qasba; Jorge Sanchez; Diane V Havlir; Beatriz Grinsztejn; Ian M Sanne; Cynthia Firnhaber
Journal:  J Clin Microbiol       Date:  2014-01-15       Impact factor: 5.948

4.  Trends and predictors of changes in pulmonary function after treatment for pulmonary tuberculosis.

Authors:  Kuei-Pin Chung; Jung-Yueh Chen; Chih-Hsin Lee; Huey-Dong Wu; Jann-Yuan Wang; Li-Na Lee; Chong-Jen Yu; Pan-Chyr Yang
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

5.  Rapid antibiotic-resistance predictions from genome sequence data for Staphylococcus aureus and Mycobacterium tuberculosis.

Authors:  Phelim Bradley; N Claire Gordon; Timothy M Walker; Laura Dunn; Simon Heys; Bill Huang; Sarah Earle; Louise J Pankhurst; Luke Anson; Mariateresa de Cesare; Paolo Piazza; Antonina A Votintseva; Tanya Golubchik; Daniel J Wilson; David H Wyllie; Roland Diel; Stefan Niemann; Silke Feuerriegel; Thomas A Kohl; Nazir Ismail; Shaheed V Omar; E Grace Smith; David Buck; Gil McVean; A Sarah Walker; Tim E A Peto; Derrick W Crook; Zamin Iqbal
Journal:  Nat Commun       Date:  2015-12-21       Impact factor: 14.919

6.  Antigen 85B peptidomic analysis allows species-specific mycobacterial identification.

Authors:  Wei Zhang; Qingbo Shu; Zhen Zhao; Jia Fan; Christopher J Lyon; Adrian M Zelazny; Ye Hu
Journal:  Clin Proteomics       Date:  2018-01-08       Impact factor: 3.988

7.  Machine Learning-Based Differentiation of Nontuberculous Mycobacteria Lung Disease and Pulmonary Tuberculosis Using CT Images.

Authors:  Zhiheng Xing; Wenlong Ding; Shuo Zhang; Lingshan Zhong; Li Wang; Jigang Wang; Kai Wang; Yi Xie; Xinqian Zhao; Nan Li; Zhaoxiang Ye
Journal:  Biomed Res Int       Date:  2020-09-29       Impact factor: 3.411

8.  Characterisation of the post-tuberculous phenotype of bronchiectasis: A real-world observational study.

Authors:  Isaac Fong; Teck Boon Low; Anthony Yii
Journal:  Chron Respir Dis       Date:  2022 Jan-Dec       Impact factor: 3.115

9.  Clinical significance of smear positivity for acid-fast bacilli after ≥5 months of treatment in patients with drug-susceptible pulmonary tuberculosis.

Authors:  Hyung Koo Kang; Byeong-Ho Jeong; Hyun Lee; Hye Yun Park; Kyeongman Jeon; Hee Jae Huh; Chang-Seok Ki; Nam Yong Lee; Won-Jung Koh
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

Review 10.  Rapid culture-based diagnosis of pulmonary tuberculosis in developed and developing countries.

Authors:  Shady Asmar; Michel Drancourt
Journal:  Front Microbiol       Date:  2015-11-03       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.